Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1984 Jan;39(1):34–39. doi: 10.1136/thx.39.1.34

Airway response to inhaled salbutamol in hyperthyroid and hypothyroid patients before and after treatment.

R N Harrison, A E Tattersfield
PMCID: PMC459718  PMID: 6695351

Abstract

For many years the development of thyrotoxicosis has been known to cause a deterioration in asthma but the mechanism is unknown. We have studied the effect of thyroid function on airway beta adrenergic responsiveness in 10 hyperthyroid and six hypothyroid subjects before and after treatment of their thyroid disease. Airway adrenergic responsiveness was assessed by measuring specific airway conductance (sGaw) after increasing doses of inhaled salbutamol (10-410 micrograms). After treatment there was no difference in resting FEV1, sGaw, or thoracic gas volume. FVC increased in the hyperthyroid subjects but did not change in the hypothyroid subjects. In the hyperthyroid subjects there was a significant increase in delta sGaw after 35, 60, 110, and 41 micrograms salbutamol; in sGaw after 60, 110, and 410 micrograms salbutamol; and in the area under the salbutamol dose response curve (AUC) after treatment of the thyroid disorder. In the hypothyroid subjects there was a significant reduction in sGaw after 10 and 60 micrograms salbutamol and in the AUC after treatment. When all subjects were considered, there was a negative correlation between the AUC and serum thyroxine values. These findings suggest that an inverse relationship exists between the level of thyroid function and airway beta adrenergic responsiveness.

Full text

PDF
34

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aoki V. S., Wilson W. R., Theilen E. O. Studies of the reputed augmentation of the cardiovascular effects of catecholamines in patients with spontaneous hyperthyroidism. J Pharmacol Exp Ther. 1972 May;181(2):362–368. [PubMed] [Google Scholar]
  2. Ayres J., Clark T. J. Asthma and the thyroid. Lancet. 1981 Nov 14;2(8255):1110–1111. doi: 10.1016/s0140-6736(81)91309-x. [DOI] [PubMed] [Google Scholar]
  3. Ayres J., Rees J., Clark T. J., Maisey M. N. Thyrotoxicosis and dyspnoea. Clin Endocrinol (Oxf) 1982 Jan;16(1):65–71. doi: 10.1111/j.1365-2265.1982.tb03148.x. [DOI] [PubMed] [Google Scholar]
  4. Bush R. K., Ehrlich E. N., Reed C. E. Thyroid disease and asthma. J Allergy Clin Immunol. 1977 May;59(5):398–401. doi: 10.1016/0091-6749(77)90025-2. [DOI] [PubMed] [Google Scholar]
  5. Christensen N. J. Plasma noradrenaline and adrenaline in patients with thyrotoxicosis and myxoedema. Clin Sci Mol Med. 1973 Aug;45(2):163–171. doi: 10.1042/cs0450163. [DOI] [PubMed] [Google Scholar]
  6. Ciaraldi T., Marinetti G. V. Thyroxine and propylthiouracil effects of vivo on alpha and beta adrenergic receptors in rat heart. Biochem Biophys Res Commun. 1977 Feb 7;74(3):984–991. doi: 10.1016/0006-291x(77)91615-1. [DOI] [PubMed] [Google Scholar]
  7. Coulombe P., Dussault J. H., Walker P. Plasma catecholamine concentrations in hyperthyroidism and hypothyroidism. Metabolism. 1976 Sep;25(9):973–979. doi: 10.1016/0026-0495(76)90126-8. [DOI] [PubMed] [Google Scholar]
  8. Esler M. Assessment of sympathetic nervous function in humans from noradrenaline plasma kinetics. Clin Sci (Lond) 1982 Mar;62(3):247–254. doi: 10.1042/cs0620247. [DOI] [PubMed] [Google Scholar]
  9. Fedrick J., Baldwin J. A. Thyroid disease and asthma. Br Med J. 1977 Dec 10;2(6101):1539–1539. doi: 10.1136/bmj.2.6101.1539-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Freedman S. Lung volumes and distensibility, and maximum respiratory pressures in thyroid disease before and after treatment. Thorax. 1978 Dec;33(6):785–790. doi: 10.1136/thx.33.6.785. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gibson A., Pollock D. The involvement of corticosteroids in the supersensitivity produced in the rat anococcygeus muscle by morphine withdrawal, thyroidectomy or a single dose of reserpine. J Pharmacol Exp Ther. 1975 Feb;192(2):390–398. [PubMed] [Google Scholar]
  12. Gribbin H. R., Baldwin C. J., Tattersfield A. E. Quantitative assessment of bronchial beta-adrenoceptor blockade in man. Br J Clin Pharmacol. 1979 Jun;7(6):551–556. doi: 10.1111/j.1365-2125.1979.tb04641.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Guarnieri T., Filburn C. R., Beard E. S., Lakatta E. G. Enhanced contractile response and protein kinase activation to threshold levels of beta-adrenergic stimulation in hyperthyroid rat heart. J Clin Invest. 1980 Apr;65(4):861–868. doi: 10.1172/JCI109738. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gutknecht D. R. Asthma complicated by iodine-induced thyrotoxicosis. N Engl J Med. 1977 May 26;296(21):1236–1236. doi: 10.1056/NEJM197705262962122. [DOI] [PubMed] [Google Scholar]
  15. HELLMAN L., BRADLOW H. L., ZUMOFF B., GALLAGHER T. F. The influence of thyroid hormone on hydrocortisone production and metabolism. J Clin Endocrinol Metab. 1961 Oct;21:1231–1247. doi: 10.1210/jcem-21-10-1231. [DOI] [PubMed] [Google Scholar]
  16. Kasperlik-Zaluska A. Stany dychawicze w przebiegu nadczynności tarczycy. Gruzlica. 1968 Jun;36(6):581–582. [PubMed] [Google Scholar]
  17. Korsager S., Ostergaard Kristensen H. P. Iodine-induced hypothyroidism and its effect on the severity of asthma. Acta Med Scand. 1979;205(1-2):115–117. doi: 10.1111/j.0954-6820.1979.tb06013.x. [DOI] [PubMed] [Google Scholar]
  18. Massey D. G., Becklake M. R., McKenzie J. M., Bates D. V. Circulatory and ventilatory response to exercise in thyrotoxicosis. N Engl J Med. 1967 May 18;276(20):1104–1112. doi: 10.1056/NEJM196705182762002. [DOI] [PubMed] [Google Scholar]
  19. McDevitt D. G., Riddell J. G., Hadden D. R., Montgomery D. A. Catecholamine sensitivity in hyperthyroidism and hypothyroidism. Br J Clin Pharmacol. 1978 Oct;6(4):297–301. doi: 10.1111/j.1365-2125.1978.tb00855.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Scarpace P. J., Abrass I. B. Thyroid hormone regulation of rat heart, lymphocyte, and lung beta-adrenergic receptors. Endocrinology. 1981 Mar;108(3):1007–1011. doi: 10.1210/endo-108-3-1007. [DOI] [PubMed] [Google Scholar]
  21. Settipane G. A., Schoenfeld E., Hamolsky M. W. Asthma and hyperthyroidism. J Allergy Clin Immunol. 1972 Jun;49(6):348–355. doi: 10.1016/0091-6749(72)90133-9. [DOI] [PubMed] [Google Scholar]
  22. Stein M., Kimbel P., Johnson R. L. PULMONARY FUNCTION IN HYPERTHYROIDISM. J Clin Invest. 1961 Feb;40(2):348–363. doi: 10.1172/JCI104262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Stoffer S. S., Jiang N. S., Gorman C. A., Pikler G. M. Plasma catecholamines in hypothyroidism and hyperthyroidism. J Clin Endocrinol Metab. 1973 Mar;36(3):587–589. doi: 10.1210/jcem-36-3-587. [DOI] [PubMed] [Google Scholar]
  24. Taylor S. E. Additional evidence against universal modulation of beta-adrenoceptor responses by excessive thyroxine. Br J Pharmacol. 1983 Apr;78(4):639–644. doi: 10.1111/j.1476-5381.1983.tb09414.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Thorsteinsson B., Kirkegaard C. Iodine-induced hyperthyroidism and bronchial asthma. Lancet. 1977 Aug 6;2(8032):294–294. doi: 10.1016/s0140-6736(77)90972-2. [DOI] [PubMed] [Google Scholar]
  26. WASSERMANN H. P. Lung volume and respiratory muscle power in hyperthyroidism. S Afr Med J. 1962 Nov 24;36:985–989. [PubMed] [Google Scholar]
  27. Williams L. T., Lefkowitz R. J., Watanabe A. M., Hathaway D. R., Besch H. R., Jr Thyroid hormone regulation of beta-adrenergic receptor number. J Biol Chem. 1977 Apr 25;252(8):2787–2789. [PubMed] [Google Scholar]
  28. Williams R. S., Guthrow C. E., Lefkowitz R. J. Beta-Adrenergic receptors of human lymphocytes are unaltered by hyperthyroidism. J Clin Endocrinol Metab. 1979 Mar;48(3):503–505. doi: 10.1210/jcem-48-3-503. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES